Veterinary Medicines

Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs

Authorised
  • Sodium glycerophosphate pentahydrate
  • Magnesium chloride hexahydrate
  • CALCIUM GLUCONATE FOR INJECTION
Download as PDF

Auðkenning lyfsins

Heiti lyfs:
Kaltetan forte, 458.4 mg/ml + 125 mg/ml + 20 mg/ml solution for infusion for horses, cattle and pigs
Kaltetan forte 458,4 mg/1 ml + 125 mg/1 ml + 20 mg/ml Roztwór do infuzji
Virkt efni:
Dýrategundir:
  • Hestur
  • Nautgripir
  • Svín
Íkomuleið:
  • Til notkunar í bláæð

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Aðeins í boði í English
    125.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Aðeins í boði í English
    458.40
    milligram(s)
    /
    1.00
    millilitre(s)
Lyfjaform:
  • Innrennslislyf, lausn
Withdrawal period by route of administration:
  • Intravenous use
    • Hestur
      • Mjólk
        5
        week
    • Nautgripir
      • Kjöt og innmatur
        5
        week
    • Svín
      • Kjöt og innmatur
        5
        week
ATC flokkun (dýralyf):
  • QA12AX
Lögformleg staða:
Staða markaðsleyfis:
  • Gilt
Authorised in:
  • Pólland
Available in:
  • Pólland
Áletrun:

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Lagagrundvöllur vöruleyfis:
Markaðsleyfishafi:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Ábyrgt yfirvald:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Markaðsleyfisnúmer:
  • 3172
Dagsetning leyfisbreytingar:
Umsjónarland (RMS):
  • Pólland
Númer verkferlis:
  • PL/V/0110/002
Þátttökulönd (CMS):
  • Búlgaría
  • Tékkland
  • Grikkland
  • Ungverjaland
  • Ítalía
  • Litáen
  • Portúgal
  • Rúmenía
  • Spánn
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."